Introduction
abnormality.
Investigation at admission revealed a haemoglobin Glomerulonephritis is an uncommon but wellof 10.6 g/dl with normal total and differential leukocyte described complication of chronic hepatitis B virus and platelet counts, serum bilirubin 0.6 mg/dl, aspart-(HBV ) infection [1] . Corticosteroids and other ate aminotransferase (AST ) 73 IU/l (normal 2-20), immunosuppressive drugs are of no benefit [2] , and alanine aminotransferase (ALT ) 85 IU/l (Normal may actually increase the morbidity and mortality [3] .
2-15), alkaline phosphatase 160 IU/l (normal 70-140), Interferon (IFN ) therapy has been used in small albumin 2.6 g/dl, globulin 3.7 g/dl, and creatinine numbers of patients with HBV-associated membranous 1 mg/dl. Urine examination revealed 3+ proteinuria and membranoproliferative glomerulonephritis [4] . We and 24-h urinary protein was 2.0 g. HBsAg and hepatreport here a case of mesangioproliferative glomeruloitis B e antigen (HBeAg) were positive after 6 months nephritis and chronic hepatitis due to HBV infection, of illness. There was no evidence of cirrhosis on who benefited from IFN therapy.
ultrasound examination of the abdomen. Light microscopy of renal biopsy tissue revealed mesangioproliferative glomerulonephritis. Immunofluorescence showed
Case
2+ deposition of immunoglobulin (Ig) G and M and complement 3 (C3) in the mesangium and along the A 23-year-old unmarried male developed jaundice pre-capillary loops. There was no deposition of IgA. Liver ceded by a typical prodrome in September 1995. biopsy, carried out after 6 months of illness, showed Jaundice persisted for 3 weeks and resolved spontan-chronic hepatitis with moderate severity of necroeously. Hepatitis B surface antigen (HBsAg) was found inflammatory activity. Immunostaining for hepatitis B to be positive, but the source of infection could not be core antigen (HBcAg) was positive. A diagnosis of identified. In the last week of December 1995 he chronic hepatitis with mesangioproliferative glomnoticed facial puffiness followed by swelling of the erulonephritis due to replicative HBV infection was whole body. He had proteinuria of 2.1 g/day and had made. been taking diuretics with which oedema subsided. In
The patient was treated with interferon a-2b (Intron March 1996 he again developed swelling of the whole A, Schering Corp., Kenilworth, NJ ), 3 MU subcutanebody and was admitted at our Institute.
ously daily for 16 weeks. In the first week of therapy There was no family history of jaundice, blood he developed mild fever, nasal stuffiness, and myalgia transfusions, or infections in the past. There were no which were treated symptomatically, and subsequently other apparent causes of HBV infection. The patient he tolerated interferon very well. Serial liver function was a social drinker. Physical examination revealed tests showed significant fall in AST and ALT after pedal oedema but no icterus, facial puffiness, or lymph-3 months and they became normal ( Figure 1) . adenopathy. His blood pressure was 120/86 mmHg. Proteinuria also gradually decreased and became nil There were no stigmata of chronic liver disease. Liver at the end of therapy. His serum albumin levels also was palpable 2 cm below right costal margin (span increased and became normal. He seroconverted and 12 cm). There was no splenomegaly or free fluid in the became HBeAg negative and anti-HBe positive at the end of the therapy. Symptomatically he was feeling better. His transaminases continued to be normal and Correspondence and offprint requests to: Dr R. K. Dhiman, Assistant proteinuria was nil 12 months after stoppage of and glomerulonephritis can be proved only by demonstrating disappearance of the glomerular abnormalities on histology with eradication of the virus. This is not easily done, for ethical reasons. However, clinical improvement of renal function abnormalities following seroconversion of virus either spontaneously or following interferon therapy as seen in our patient can be of use in proving this relationship.
The natural history of HBV-related glomerulonephritis is now well characterized [4] [5] [6] [7] . Seroconversion to anti-HBe is associated with remission of proteinuria. Spontaneous remissions are common in children, these are rare in adults, but are more frequent with IFN therapy [2, 6, 7] . Our patient had repticative HBV infection and proteinuria; the clearance of HBeAg and remission in the proteinuria that occurred following interferon therapy suggests the role of IFN in the seroconversion as well as in the remission of proteinuria. However, the remote possibility of a spontaneous remission cannot be totally excluded. The response to IFN therapy found in patients with glomerulonephritis is higher than seen in patients with chronic hepatitis B [4] . Conjeevaram et al. [4] have reported a small series of 15 patients with chronic hepatitis B and glomerulonephritis (membranous 10, and membranoproliferative 5) treated with IFN, and have shown a long-term serological response with sustained loss of HBeAg and HBV DNA in eight (53%) patients. Seven of eight responders have also shown a gradual but marked improvement in proteinuria. Lin [7] has reported the effect of IFN treatment in 40 children with HBV membranous Cases treated with IFN reported so far have had This case suggests the association of mesangioprolifereither membranous or mesangiocapillary glomeruloative glomerulonephritis with chronic hepatitis due to nephritis [4] . Response is better in membranous as replicative HBV. Proteinuria subsided with seroconvercompared to mesangiocapillary glomerulonephritis [4] . sion to anti-HBe and loss of HBeAg after adequate
In a recent study on the therapeutic effects of IFN on interferon therapy, suggesting the pathogenetic role of HBV-associated glomerulonephritis, two patients with HBV in producing mesangioproliferative glomerulomesangioproliferative glomerulonephritis were also nephritis and role of interferon therapy in this included [8] . Both patients in this study showed remissituation. sion of proteinuria with or without seroconversion to Several histological findings have been reported in anti-HBe [8]. renal biopsies obtained from patients with glomeruloOur patient had mesangioproliferative glomerulonephritis associated with chronic HBV infection; these nephritis and had remission of proteinuria along with include, membranous, membranoproliferative, mes-seroconversion following IFN therapy. We therefore angiocapillary, and mesangioproliferative glomerulo-believe that mesangioproliferative glomerulonephritis nephritis, and focal glomerulosclerosis [1,2]. The in our patient was associated with HBV infection and pathogenesis of hepatitis B glomerulonephritis remains it responded to interferon therapy. unknown. All the major hepatitis B virus antigens,
We conclude that mesangioproliferative glomeruloincluding HBsAg, HBeAg, and HBcAg, have been nephritis can be associated with chronic HBV infection located in the glomercular capillary wall or in the and responds well to therapy with IFN. mesangium. This could be a result of non-specific passive trapping of immune complexes containing
